|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,843.24 |
3.21% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$66,601.35 |
3.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$54,774.43 |
2.52% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$54,520.32 |
2.51% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$49,333.32 |
2.27% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$49,051.36 |
2.26% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,651.35 |
2.24% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,610.00 |
2.19% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$47,202.36 |
2.17% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$46,958.89 |
2.16% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,033.36 |
2.16% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,536.29 |
2.14% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$46,038.72 |
2.12% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$46,191.21 |
2.12% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,885.07 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,876.39 |
2.11% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,098.43 |
2.03% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,906.35 |
2.02% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$43,621.90 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,388.50 |
2.00% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$43,391.88 |
2.00% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,402.58 |
2.00% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$43,367.84 |
1.99% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,959.78 |
1.98% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,798.96 |
1.97% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$42,249.72 |
1.94% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,879.04 |
1.93% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$41,248.80 |
1.90% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$40,813.52 |
1.88% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,767.54 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,098.20 |
1.84% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$40,061.86 |
1.84% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$39,875.17 |
1.83% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$39,406.18 |
1.81% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$39,411.82 |
1.81% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$39,447.82 |
1.81% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,089.85 |
1.80% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,840.23 |
1.79% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$38,643.30 |
1.78% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$38,284.19 |
1.76% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,341.92 |
1.76% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,167.72 |
1.76% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,901.92 |
1.74% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,863.07 |
1.74% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$37,678.54 |
1.73% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,113.09 |
1.71% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,801.99 |
1.69% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$36,708.08 |
1.69% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$35,315.79 |
1.62% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,303.52 |
1.49% |
| US Dollar |
$USD |
|
2,483 |
$2,483.10 |
0.11% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|